 - Correlate potential endpoints, including phosphorylated ERK, PKB, and SAPK, phosphorylated PKC alpha, beta, and gamma isoforms, p21 WAF1; and activated capase-3 in tumor biopsies, with clinical outcome in patients treated with this drug. 